Inventor · disambiguated record
Yves Guminski
Also filed as: GUMINSKI YVES
15 granted patents·3 pending applications·54 citations·filing 1995–2015
89Inventor score
Top patents by PatentIndex Score
18 records- 0182US7846926B2(Poly)aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agentsPF MEDICAMENT·Filed 2005·Granted Dec 7, 2010·5 cites·8 claims
- 0277US7932406B2Method for preparing 4β-amino-4′-demethyl-4-desoxypodophyllotoxinPF MEDICAMENT·Filed 2006·Granted Apr 26, 2011·2 cites·9 claims
- 0369US8193379B2Method for preparing 4B-amino-4′-demethyl-4-desoxypodophyllotoxinGUMINSKI YVES·Filed 2010·Granted Jun 5, 2012·1 cites·20 claims
- 0465US5663173AN-[(1,4-diazabicyclo[2.2.2] oct-2-yl)methyl] benzamide derivatives, their preparations and their application in therapeuticsSYNTHELABO·Filed 1996·Granted Sep 2, 1997·22 cites·12 claims
- 0561US8288567B2(Poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agentsIMBERT THIERRY·Filed 2009·Granted Oct 16, 2012·0 cites·12 claims
- 0661US6008382AMethod for preparing 4'-Demethylepipodophyllotoxin from podophyllotoxinPF MEDICAMENT·Filed 1996·Granted Dec 28, 1999·8 cites·6 claims
- 0758US6107284AWater-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatmentsPF MEDICAMENT·Filed 1995·Granted Aug 22, 2000·16 cites·14 claims
- 0856US2010202975A1Novel fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumorsPF MEDICAMENT·Filed 2008·Application pending·0 cites
- 0950US8492567B2(Poly)Aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agentsIMBERT THIERRY·Filed 2012·Granted Jul 23, 2013·0 cites·10 claims
- 1048US9403840B2(Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agentsPF MEDICAMENT·Filed 2015·Granted Aug 2, 2016·0 cites·7 claims
- 1148US9216989B2(Poly) aminoacetamide derivatives of epipodophyllotoxin their process of preparation and their applications in therapeutics as anticancer agentsIMBERT THIERRY·Filed 2010·Granted Dec 22, 2015·0 cites·5 claims
- 1247US8664409B2Process for the preparation of (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxin useful for their applications in therapeutics as anticancer agentGUMINSKI YVES·Filed 2008·Granted Mar 4, 2014·0 cites·18 claims
- 1347US8148552B2Process for the synthesis of anticancer (poly) aminoalkylaminoacetamide derivatives of epipodophyllotoxinGUMINSKI YVES·Filed 2008·Granted Apr 3, 2012·0 cites·16 claims
- 1446US2007042971A1Crystalline compound of 4'-demethyl-4'-phosphate-2", 3"-bispentafluorophenoxy-acetyl-4", 6"-ethylidene-beta-d-epipodophyllotoxin glucoside either in its free form or solvated with ethanolPF MEDICAMENT·Filed 2004·Application pending·0 cites
- 1545US8569011B2Fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumorsANNEREAU JEAN-PHILIPPE·Filed 2012·Granted Oct 29, 2013·0 cites·12 claims
- 1635US9439982B2Fluorescent cyanine-polyamine derivatives as a diagnostic probeGUMINSKI YVES·Filed 2011·Granted Sep 13, 2016·0 cites·10 claims
- 1730US2013171067A1TECHNETIUM-99m COMPLEX AS A TOOL FOR THE IN VIVO DIAGNOSIS OF CANCEROUS TUMOURSGUMINSKI YVES·Filed 2011·Application pending·0 cites
- 1824US8785424B2ngCycloartanone derivatives with anticancer activityLONG CHRISTOPHE·Filed 2010·Granted Jul 22, 2014·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Yves Guminski files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →